Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   In utero exposure to diethylstilbestrol and blood DNA methylation in adult women: Results from a meta-analysis of two cohort studies
  2. Bodelon, Clara; Gierach, Gretchen L; Hatch, Elizabeth E; Riseberg, Emily; Hutchinson,Amy; Yeager,Meredith; Sandler, Dale P; Taylor, Jack A; Hoover, Robert N; Xu, Zongli; Titus, Linda; Palmer, Julie R; Troisi, Rebecca
  3. Environmental Research. 2023, Aug 15; 231(Pt. 1): 115990.
  1. 2.   Substitution of a triazole for the central olefin in biologically active stilbenes
  2. Stockdale, David P; Beutler,John; Wiemer, David F
  3. Bioorganic & Medicinal Chemistry Letters. 2022, Sep 09; 128980.
  1. 3.   Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis
  2. Park, Jung-Eun; Zhang, Liang; Bang, Jeong Kyu; Andresson,Thorkell; DiMaio, Frank; Lee, Kyung S
  3. Nature communications. 2019, Oct 31; 10(1): 4959.
  1. 4.   Synthesis of amide isosteres of schweinfurthin-based stilbenes
  2. Stockdale, David P; Beutler, John; Wiemer, David F
  3. Bioorganic & medicinal chemistry. 2017, Oct 15; 25(20): 5483-5489.
  1. 5.   Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene
  2. Chan, Chi Ngai; Trinite, Benjamin; Levy, David N.
  3. Antimicrobial Agents and Chemotherapy. 2017, Aug 24; 61(9): e00408-17.
  1. 6.   Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology Letters. 2012, Mar; 209(2): 179-185.
  1. 7.   Relevance of the C-5 position to schweinfurthin induced cytotoxicity
  2. Topczewski, J. J.; Callahan, M. P.; Kodet, J. G.; Inbarasu, J. D.; Mente, N. R.; Beutler, J. A.; Wiemer, D. F.
  3. Bioorganic & Medicinal Chemistry. 2011, Dec; 19(24): 7570-7581.
  1. 8.   Structure-activity relationships of ustiloxin analogues
  2. Joullie, M. M.; Berritt, S.; Hamel, E.
  3. Tetrahedron Letters. 2011, Apr; 52(17): 2136-2139.
  1. 9.   Carcinogenic Effects of "Whole-Life" Exposure to Inorganic Arsenic in CD1 Mice
  2. Tokar, E. J.; Diwan, B. A.; Ward, J. M.; Delker, D. A.; Waalkes, M. P.
  3. Toxicological Sciences. 2011, Jan; 119(1): 73-83.
  1. 11.   Arsenic Exposure In Utero and Nonepidermal Proliferative Response in Adulthood in Tg.AC Mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. International Journal of Toxicology. 2010, May; 29(3): 291-296.
  1. 12.   Structural analogues of schweinfurthin F: Probing the steric, electronic, and hydrophobic properties of the D-ring substructure
  2. Ulrich, N. C.; Kodet, J. G.; Mente, N. R.; Kuder, C. H.; Beutler, J. A.; Hohl, R. J.; Wiemer, D. F.
  3. Bioorganic & Medicinal Chemistry. 2010, Feb; 18(4): 1676-1683.
  1. 13.   Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal
  2. Liu, J.; Yu, L. M.; Coppin, J. F.; Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. Chemico-Biological Interactions. 2009 182(2-3): 253-258.
  1. 14.   Transplacental arsenic carcinogenesis in mice
  2. Waalkes, M. P.; Liu, J.; Diwan, B. A.
  3. Toxicology and Applied Pharmacology. 2007, Aug; 222(3): 271-280.
  1. 15.   Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic
  2. Xie, Y. X.; Liu, J.; Benbrahim-Tallaa, L.; Ward, J. M.; Logsdon, D.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology. 2007, Jul; 236(1-2): 7-15.
  1. 16.   Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism
  2. Liu, J.; Xie, Y. X.; Cooper, R.; Duchanne, D. M. K.; Tennant, R.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2007, May; 220(3): 284-291.
  1. 17.   Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: Differences of bioactivity in the enantiomeric series
  2. Mente, N. R.; Wiemer, A. J.; Neighbors, J. D.; Beutler, J. A.; Hohl, R. J.; Wiemer, D. F.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Feb; 17(4): 911-915.
  1. 18.   4,5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids: Synthesis and evaluation as anti-mitotic and cytotoxic agents
  2. Banwell, M. G.; Hamel, E.; Hockless, D. C. R.; Verdier-Pinard, P.; Willis, A. C.; Wong, D. J.
  3. Bioorganic & Medicinal Chemistry. 2006, Jul; 14(13): 4627-4638.
  1. 19.   Synthesis and structure-activity studies of schweinfurthin B analogs: Evidence for the importance of a D-ring hydrogen bond donor in expression of differential cytotoxicity
  2. Neighbors, J. D.; Salnikova, M. S.; Beutler, J. A.; Wiemer, D. F.
  3. Bioorganic & Medicinal Chemistry. 2006, Mar; 14(6): 1771-1784.
  1. 20.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 21.   Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines
  2. Simoni, D.; Grisolia, G.; Giannini, G.; Roberti, M.; Rondanin, R.; Piccagli, L.; Baruchello, R.; Rossi, M.; Romagnoli, R.; Invidiata, F. P.; Grimaudo, S.; Jung, M. K.; Hamel, E.; Gebbia, N.; Crosta, L.; Abbadessa, V.; Di Cristina, A.; Dusonchet, L.; Meli, M.; Tolomeo, M.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 723-736.
  1. 22.   Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 85-90.
  1. 23.   Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 162-174.
  1. 24.   Natural inhibitors of carcinogenesis
  2. Kinghorn, A. D.; Su, B. N.; Jang, D. S.; Chang, L. C.; Lee, D.; Gu, J. Q.; Carcache-Blanco, E. J.; Powlus, A. D.; Lee, S. K.; Park, E. J.; Cuendet, M.; Gills, J. J.; Bhat, K.; Park, H. S.; Mata-Greenwood, E.; Song, L. L.; Jong, M. H.; Pezzuto, J. M.
  3. Planta Medica. 2004, AUG; 70(8): 691-705.
  1. 25.   Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: Role of glutathione S-transferase genotypes
  2. Hakim, I. A.; Harris, R. B.; Chow, H. H. S.; Dean, M.; Brown, S.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004 13(2): 242-249.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel